Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP633539.RApfYUKkglKebP8V3TBj5Pl6CUTv4JU6OTFcstZG9JnJ0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP633539.RApfYUKkglKebP8V3TBj5Pl6CUTv4JU6OTFcstZG9JnJ0130_assertion type Assertion NP633539.RApfYUKkglKebP8V3TBj5Pl6CUTv4JU6OTFcstZG9JnJ0130_head.
- NP633539.RApfYUKkglKebP8V3TBj5Pl6CUTv4JU6OTFcstZG9JnJ0130_assertion description "[Combined, these findings define a novel transcriptional network regulating oncogenic EGFR signaling and identify a class of FDA-approved drugs as capable of restoring chemosensitivity to anti-EGFR-based therapy for the treatment of metastatic lung adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP633539.RApfYUKkglKebP8V3TBj5Pl6CUTv4JU6OTFcstZG9JnJ0130_provenance.
- NP633539.RApfYUKkglKebP8V3TBj5Pl6CUTv4JU6OTFcstZG9JnJ0130_assertion evidence source_evidence_literature NP633539.RApfYUKkglKebP8V3TBj5Pl6CUTv4JU6OTFcstZG9JnJ0130_provenance.
- NP633539.RApfYUKkglKebP8V3TBj5Pl6CUTv4JU6OTFcstZG9JnJ0130_assertion SIO_000772 22653055 NP633539.RApfYUKkglKebP8V3TBj5Pl6CUTv4JU6OTFcstZG9JnJ0130_provenance.
- NP633539.RApfYUKkglKebP8V3TBj5Pl6CUTv4JU6OTFcstZG9JnJ0130_assertion wasDerivedFrom befree-20140225 NP633539.RApfYUKkglKebP8V3TBj5Pl6CUTv4JU6OTFcstZG9JnJ0130_provenance.
- NP633539.RApfYUKkglKebP8V3TBj5Pl6CUTv4JU6OTFcstZG9JnJ0130_assertion wasGeneratedBy ECO_0000203 NP633539.RApfYUKkglKebP8V3TBj5Pl6CUTv4JU6OTFcstZG9JnJ0130_provenance.